PHOENIX, June 30, 2025 /PRNewswire/ -- Last week CIAI announced the launch of ciATHENA, a next generation Agentic AI platform built to accelerate commercial analytics across life sciences ...

– Nuvisertib (TP-3654), an investigational highly selective oral PIM1 kinase inhibitor, is being evaluated in patients with relapsed or refractory myelofibrosis (MF) – – Nuvisertib ...

The global Pharmaceutical Membrane Filtration market, valued at $10.8 billion in 2024, is expected to reach $19.6 billion by 2030, growing at a 10.5% CAGR. Key drivers include rising ...

The pharmaceutical filtration market is experiencing a steady growth with a CAGR of around 9% during the forecast period. The market growth is primarily fueled by the increasing production of ...

Market OverviewThe pharmaceutical filtration market plays a crucial role in ensuring the safety, purity, and efficacy of pharmaceutical products. From drug discovery and development to ...

People Moves The Escalator: Astellas Pharma, Moderna, Minds + Assembly and more See which leaders are on the move across the pharma, biotech and medical marketing industries.

TheSpecialty Excipients for Parenteral Pharmaceuticals Market Research Report 2024-2034, Profiles of BASF, Merck, Ashland Global, Croda, Dow Chemical, Roquette Freres, Clariant, HPC, & JRS Pharma ...

Meiji Seika Pharma plans to supply the domestically produced next-generation sa-mRNA vaccine (replicon) ‘KOSTAIVE® for Intramuscular Injection’ in December 2024.

The fundamentals of developing parenteral drug products Advancing to first-in-human clinical trials requires formulation development to design a successful sterile formulation that meets your Target ...

Parenteral Drug Association is ensuring drug shortage effects are minimal in a post pandemic world Sponsored By Parenteral Drug Association (PDA) Sep 30, 2024 8:00am Pharma ...